Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

975 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease.
Guidi L, Pugliese D, Panici Tonucci T, Bertani L, Costa F, Privitera G, Tolusso B, Di Mario C, Albano E, Tapete G, Gremese E, Papa A, Gasbarrini A, Rapaccini GL, Armuzzi A. Guidi L, et al. Among authors: di mario c. United European Gastroenterol J. 2019 Nov;7(9):1189-1197. doi: 10.1177/2050640619873784. Epub 2019 Sep 3. United European Gastroenterol J. 2019. PMID: 31700632 Free PMC article.
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients.
Pugliese D, Guidi L, Privitera G, Bertani L, Tolusso B, Papparella LG, Maltinti S, Di Mario C, Onali S, Ceccarelli L, Rapaccini GL, Scaldaferri F, Gremese E, Gasbarrini A, Costa F, Armuzzi A. Pugliese D, et al. Among authors: di mario c. Expert Opin Biol Ther. 2021 Jan;21(1):97-104. doi: 10.1080/14712598.2020.1839045. Epub 2020 Oct 31. Expert Opin Biol Ther. 2021. PMID: 33074723
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report.
Caruso C, Colantuono S, Pugliese D, Di Mario C, Tolusso B, Gremese E, Papparella G, Castrì F, Gasbarrini A, Romano A, Armuzzi A. Caruso C, et al. Among authors: di mario c. Allergy Asthma Clin Immunol. 2020 Apr 22;16:27. doi: 10.1186/s13223-020-00423-3. eCollection 2020. Allergy Asthma Clin Immunol. 2020. PMID: 32336975 Free PMC article.
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study.
Bosello S, De Luca G, Berardi G, Canestrari G, de Waure C, Gabrielli FA, Di Mario C, Forni F, Gremese E, Ferraccioli G. Bosello S, et al. Among authors: di mario c. Eur J Intern Med. 2019 Feb;60:46-53. doi: 10.1016/j.ejim.2018.10.013. Epub 2018 Oct 23. Eur J Intern Med. 2019. PMID: 30366614
The B side of rheumatoid arthritis pathogenesis.
Alivernini S, Tolusso B, Fedele AL, Di Mario C, Ferraccioli G, Gremese E. Alivernini S, et al. Among authors: di mario c. Pharmacol Res. 2019 Nov;149:104465. doi: 10.1016/j.phrs.2019.104465. Epub 2019 Sep 28. Pharmacol Res. 2019. PMID: 31574298 Review.
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study.
Bruno D, Fedele AL, Tolusso B, Barini A, Petricca L, Di Mario C, Barini A, Mirone L, Ferraccioli G, Alivernini S, Gremese E. Bruno D, et al. Among authors: di mario c. Front Med (Lausanne). 2021 Feb 25;8:613889. doi: 10.3389/fmed.2021.613889. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33732715 Free PMC article.
975 results